1. Home
  2. EMBC vs DCO Comparison

EMBC vs DCO Comparison

Compare EMBC & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • DCO
  • Stock Information
  • Founded
  • EMBC 1924
  • DCO 1849
  • Country
  • EMBC United States
  • DCO United States
  • Employees
  • EMBC N/A
  • DCO N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • DCO Military/Government/Technical
  • Sector
  • EMBC Health Care
  • DCO Industrials
  • Exchange
  • EMBC Nasdaq
  • DCO Nasdaq
  • Market Cap
  • EMBC 1.0B
  • DCO 1.0B
  • IPO Year
  • EMBC N/A
  • DCO N/A
  • Fundamental
  • Price
  • EMBC $14.10
  • DCO $61.26
  • Analyst Decision
  • EMBC Buy
  • DCO Strong Buy
  • Analyst Count
  • EMBC 2
  • DCO 4
  • Target Price
  • EMBC $19.00
  • DCO $73.50
  • AVG Volume (30 Days)
  • EMBC 441.4K
  • DCO 72.4K
  • Earning Date
  • EMBC 02-06-2025
  • DCO 02-27-2025
  • Dividend Yield
  • EMBC 4.25%
  • DCO N/A
  • EPS Growth
  • EMBC 2.96
  • DCO 41.24
  • EPS
  • EMBC 0.99
  • DCO 2.00
  • Revenue
  • EMBC $1,107,700,000.00
  • DCO $781,490,000.00
  • Revenue This Year
  • EMBC $0.26
  • DCO $4.72
  • Revenue Next Year
  • EMBC $1.24
  • DCO $5.51
  • P/E Ratio
  • EMBC $14.24
  • DCO $30.70
  • Revenue Growth
  • EMBC N/A
  • DCO 3.78
  • 52 Week Low
  • EMBC $9.93
  • DCO $47.53
  • 52 Week High
  • EMBC $21.48
  • DCO $70.50
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 22.61
  • DCO 29.54
  • Support Level
  • EMBC $14.55
  • DCO $61.95
  • Resistance Level
  • EMBC $15.72
  • DCO $63.27
  • Average True Range (ATR)
  • EMBC 0.91
  • DCO 1.73
  • MACD
  • EMBC -0.33
  • DCO -0.73
  • Stochastic Oscillator
  • EMBC 6.28
  • DCO 9.60

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: